Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Active Site Residues Contribute to the Multistep Dynamics of Dicyclotyrosine Bound to CYP121A1 of Mycobacterium tuberculosis.

Created on 22 Oct 2025

Authors

Patil Pranita Uttamrao, Layne J Jensen, D Fernando Estrada, Thenmalarchelvi Rathinavelan

Published in

Biochemistry. Oct 22, 2025. Epub Oct 22, 2025.

Abstract

Cytochrome P450 121A1 (CYP121A1) of Mycobacterium tuberculosis is involved in the essential synthesis of mycocyclosin from its substrate, dicyclotyrosine (cYY). As such, CYP121A1 continues to garner significant interest as a drug target. In this study, all-atom molecular dynamics simulations have been employed to investigate the behavior of bound cYY in wild-type CYP121A1, as well as mutants of the active site aromatic residues F168 and W182 that have previously been characterized in vitro. Of note, simulated changes in cYY orientation align closely with changes in CYP121A1 catalysis described in vitro. For example, the mutant W182Y allows cYY to achieve proximity to the heme, which we posit models a catalytically relevant binding mode. Interestingly, a similar binding mode was observed for a single CYP121 protomer in simulations of the intact dimer. These findings, including in vitro analysis of the active site mutation R386N, inform a model of the multistep dynamics of bound cYY and address multiple unresolved questions raised in prior studies while also informing the development of future drug design by highlighting additional orientations of bound cYY that correlate with CYP121A1 function.

PMID:
41122809
Bibliographic data and abstract were imported from PubMed on 22 Oct 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 55
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement